Trial Profile
Measurement of the Structural Efficacy in Active Rheumatoid Arthritis (RA) Patients Treated With Sarilumab in Combination With Methotrexate (MTX) and Naive to Biologics as Measured by Low-field MRI Using a Modified OMERACT-RAMRIS Score.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 04 Aug 2022
Price :
$35
*
At a glance
- Drugs Sarilumab (Primary) ; Methotrexate; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 10 Aug 2020 Planned primary completion date changed from 30 Jun 2020 to 30 Dec 2020.
- 10 Aug 2020 Status changed from recruiting to active, no longer recruiting.
- 02 Jul 2019 Planned End Date changed from 30 Jul 2020 to 30 Dec 2020.